IBDEI1B6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22246,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,22247,0)
 ;;=R39.16^^87^977^95
 ;;^UTILITY(U,$J,358.3,22247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22247,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,22247,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,22247,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,22248,0)
 ;;=R36.0^^87^977^97
 ;;^UTILITY(U,$J,358.3,22248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22248,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,22248,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,22248,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,22249,0)
 ;;=R36.9^^87^977^98
 ;;^UTILITY(U,$J,358.3,22249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22249,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,22249,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,22249,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,22250,0)
 ;;=R97.2^^87^977^27
 ;;^UTILITY(U,$J,358.3,22250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22250,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,22250,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,22250,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,22251,0)
 ;;=R80.1^^87^977^87
 ;;^UTILITY(U,$J,358.3,22251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22251,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,22251,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,22251,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,22252,0)
 ;;=R80.0^^87^977^85
 ;;^UTILITY(U,$J,358.3,22252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22252,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,22252,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,22252,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,22253,0)
 ;;=R80.8^^87^977^88
 ;;^UTILITY(U,$J,358.3,22253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22253,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,22253,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,22253,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,22254,0)
 ;;=R80.3^^87^977^84
 ;;^UTILITY(U,$J,358.3,22254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22254,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,22254,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,22254,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,22255,0)
 ;;=R80.9^^87^977^89
 ;;^UTILITY(U,$J,358.3,22255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22255,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,22255,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,22255,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,22256,0)
 ;;=Z87.442^^87^977^77
 ;;^UTILITY(U,$J,358.3,22256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22256,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,22256,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,22256,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,22257,0)
 ;;=N18.1^^87^977^13
 ;;^UTILITY(U,$J,358.3,22257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22257,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,22257,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,22257,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,22258,0)
 ;;=N18.2^^87^977^14
 ;;^UTILITY(U,$J,358.3,22258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22258,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,22258,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,22258,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,22259,0)
 ;;=N18.3^^87^977^15
 ;;^UTILITY(U,$J,358.3,22259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22259,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,22259,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,22259,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,22260,0)
 ;;=N18.4^^87^977^16
 ;;^UTILITY(U,$J,358.3,22260,1,0)
 ;;=^358.31IA^4^2
